In addition, there was no significant difference in the level of neuron-specific enolase (NSE) between the sporadic AD and control samples (Table 1), indicating that the lower PrPC in the sporadic AD samples was not caused by neuronal loss. The gene discussed is ENO2; the disease is Alzheimer disease.